scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 53,364,241
- Total 13F shares
- 17,536,133
- Share change
- +5,047,553
- Total reported value
- $129,064,483
- Price per share
- $7.36
- Number of holders
- 51
- Value change
- +$37,153,425
- Number of buys
- 42
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 810648105?
CUSIP 810648105 identifies SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 810648105:
Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
6.6%
|
3,518,998
|
$26,041,000 | — | 31 Mar 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
6.4%
|
3,409,865
|
$25,233,000 | — | 31 Mar 2020 | |
| 5AM Venture Management, LLC |
13F
|
Company |
6.1%
|
3,253,440
|
$24,075,000 | — | 31 Mar 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
2%
|
1,073,647
|
$7,945,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.46%
|
243,965
|
$1,805,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.36%
|
192,486
|
$1,424,000 | — | 31 Mar 2020 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.27%
|
143,646
|
$1,063,000 | — | 31 Mar 2020 | |
| Eversept Partners, LP |
13F
|
Company |
0.25%
|
132,419
|
$979,901 | — | 31 Mar 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
115,388
|
$854,000 | — | 31 Mar 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
64,200
|
$475,000 | — | 31 Mar 2020 | |
| Alambic Investment Management, L.P. |
13F
|
Company |
0.08%
|
41,523
|
$307,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.08%
|
41,172
|
$305,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
40,502
|
$300,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
35,059
|
$259,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
31,028
|
$229,000 | — | 31 Mar 2020 | |
| Matisse Capital |
13F
|
Company |
0.05%
|
27,685
|
$205,000 | — | 31 Mar 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
21,802
|
$161,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
20,212
|
$150,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
17,148
|
$127,000 | — | 31 Mar 2020 | |
| Trexquant Investment LP |
13F
|
Company |
0.03%
|
16,680
|
$123,000 | — | 31 Mar 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.03%
|
15,870
|
$117,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
11,759
|
$87,000 | — | 31 Mar 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
10,347
|
$76,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
2,729
|
$20,000 | — | 31 Mar 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.01%
|
2,710
|
$20,000 | — | 31 Mar 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,601
|
$12,000 | — | 31 Mar 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
953
|
$7,000 | — | 31 Mar 2020 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
729
|
$6,000 | — | 31 Mar 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
357
|
$3,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
342
|
$3,000 | — | 31 Mar 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
117
|
$1,000 | — | 31 Mar 2020 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
36
|
$266 | — | 31 Mar 2020 |
Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q2 2020
As of 30 Jun 2020,
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,536,133 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, 5AM Venture Management, LLC, RA CAPITAL MANAGEMENT, L.P., Ikarian Capital, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., and Eversept Partners, LP.
This page lists
51
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
32
Q2 2020 holders
51
Holder diff
19
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.